Skip to main content
| Hans-Günter Meyer-Thompson | Legal

USA. Purdue Pharma Announces Agreement in Principle on Landmark Opioid Litigation Settlemen

USA. Purdue Pharma Announces Agreement in Principle on Landmark Opioid Litigation Settlement

STAMFORD, Conn., September 15, 2019. Purdue’s entire value to be contributed for the benefit of the American public. Settlement is estimated to provide more than $10 billion of value to address opioid crisis, including potentially contributing millions of doses of life-saving opioid overdose reversal medications. Purdue to use Chapter 11 reorganization to finalize and implement settlement agreement.

https://www.purduepharma.com/news/2019/09/16/purdue-pharma-announces-agreement-in-principle-on-landmark-opioid-litigation-settlement/